We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$4B
AUM Growth
+$132M
Cap. Flow
-$179M
Cap. Flow %
-4.48%
Top 10 Hldgs %
18.79%
Holding
1,371
New
119
Increased
418
Reduced
646
Closed
96

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$6.17M
2
CARR icon
Carrier Global
CARR
+$5.55M
3
LOW icon
Lowe's Companies
LOW
+$5.28M
4
ZTS icon
Zoetis
ZTS
+$5.18M
5
PENN icon
PENN Entertainment
PENN
+$5.17M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$22.3M
2
AAPL icon
Apple
AAPL
+$19M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$14.4M
4
META icon
Meta Platforms (Facebook)
META
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$11M

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 12.39%
3 Consumer Discretionary 10.38%
4 Financials 10.05%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MR
1251
DELISTED
Montage Resources Corporation Common Stock
MR
$62K ﹤0.01%
+14,200
New +$65.7K
VNRX icon
1252
VolitionRx Ltd
VNRX
$8.65M
$60K ﹤0.01%
939
PSEC icon
1253
Prospect Capital
PSEC
$1.07B
$59K ﹤0.01%
11,725
-2,865
-20% -$14.4K
WTER
1254
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$56K ﹤0.01%
2,947
+654
+29% +$17K
CPE
1255
DELISTED
Callon Petroleum Company
CPE
$54K ﹤0.01%
11,200
-1,000
-8% -$8.82K
FPL
1256
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$51K ﹤0.01%
14,277
+1,234
+9% +$4.91K
NGD
1257
DELISTED
New Gold Inc
NGD
$50K ﹤0.01%
29,446
PVLA
1258
Palvella Therapeutics
PVLA
$1.99B
$50K ﹤0.01%
300
-10
-3% -$2.28K
TOON icon
1259
Kartoon Studios
TOON
$35.2M
$49K ﹤0.01%
+4,150
New +$64.9K
WATT icon
1260
Energous
WATT
$77.6M
$47K ﹤0.01%
27
-8
-23% -$15.7K
RIG icon
1261
Transocean
RIG
$5.89B
$45K ﹤0.01%
56,326
-1,119
-2% -$1.83K
VCNX
1262
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$42K ﹤0.01%
112
-56
-33% -$61.1K
AGRX
1263
DELISTED
Agile Therapeutics
AGRX
$42K ﹤0.01%
7
-6
-46% -$34.4K
PDLI
1264
DELISTED
PDL BioPharma, Inc.
PDLI
$42K ﹤0.01%
13,188
-2,000
-13% -$6.39K
GRCE
1265
Grace Therapeutics
GRCE
$33.8M
$39K ﹤0.01%
4,058
-75
-2% -$1.95K
MLSS icon
1266
Milestone Scientific
MLSS
$35.3M
$38K ﹤0.01%
+27,500
New +$48K
MNKD icon
1267
MannKind Corp
MNKD
$1.21B
$22K ﹤0.01%
+11,700
New +$20.2K
ATHX
1268
DELISTED
Athersys, Inc. Common Stock
ATHX
$20K ﹤0.01%
400
WRN
1269
Western Copper and Gold
WRN
$460M
$12K ﹤0.01%
10,000
DMK
1270
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$9K ﹤0.01%
171
-58
-25% -$3.44K
OTLK icon
1271
Outlook Therapeutics
OTLK
$183M
$7K ﹤0.01%
+500
New +$11.1K
SENS icon
1272
Senseonics Holdings Inc
SENS
$263M
$4K ﹤0.01%
500
GSAT icon
1273
Globalstar
GSAT
$10.7B
$3K ﹤0.01%
667
AIV
1274
Aimco
AIV
$387M
-50,236
Closed -$252K
AMC icon
1275
AMC Entertainment Holdings
AMC
$2.52B
-2,029
Closed -$87K

Similar funds

Oppenheimer & Co's Q3 2020 Portfolio in Review

As of Q3 2020, Oppenheimer & Co held 1,371 positions worth $4B, up 3.4% from $3.87B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co withdrew a net $179M in Q3 2020, closing 96 positions and reducing 646 holdings. Its most notable exit was Chegg, an estimated $5.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Oppenheimer & Co opened a new position in PENN Entertainment worth $7.66M.

  • Oppenheimer & Co's largest Q3 2020 buy was PENN Entertainment: 105,394 shares worth $7.66M.
  • Oppenheimer & Co added most to Illumina in Q3 2020, an estimated $6.17M increase.
  • Oppenheimer & Co's biggest Q3 2020 reduction was Amazon, cutting an estimated $22.3M.
  • Oppenheimer & Co fully exited Chegg in Q3 2020, selling an estimated $5.41M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $4B portfolio in Q3 2020.
  • Oppenheimer & Co opened 119 new positions and closed 96 in Q3 2020.
  • Oppenheimer & Co's portfolio value rose 3.4% quarter-over-quarter to $4B.

Based on Oppenheimer & Co's 13F filing for Q3 2020, filed 13 Nov 2020.